Comprehensive Multimodal Deep Learning Survival Prediction Enabled by a Transformer Architecture: A Multicenter Study in Glioblastoma
Not on the map. Why?
Abstract (arXiv)
Background: This research aims to improve glioblastoma survival prediction by integrating MR images, clinical and molecular-pathologic data in a transformer-based deep learning model, addressing data heterogeneity and performance generalizability. Method: We propose and evaluate a transformer-based non-linear and non-proportional survival prediction model. The model employs self-supervised learning techniques to effectively encode the high-dimensional MRI input for integration with non-imaging data using cross-attention. To demonstrate model generalizability, the model is assessed with the time-dependent concordance index (Cdt) in two training setups using three independent public test sets: UPenn-GBM, UCSF-PDGM, and RHUH-GBM, each comprising 378, 366, and 36 cases, respectively. Results: The proposed transformer model achieved promising performance for imaging as well as non-imaging data, effectively integrating both modalities for enhanced performance (UPenn-GBM test-set, imaging Cdt 0.645, multimodal Cdt 0.707) while outperforming state-of-the-art late-fusion 3D-CNN-based models. Consistent performance was observed across the three independent multicenter test sets with Cdt values of 0.707 (UPenn-GBM, internal test set), 0.672 (UCSF-PDGM, first external test set) and 0.618 (RHUH-GBM, second external test set). The model achieved significant discrimination between patients with favorable and unfavorable survival for all three datasets (logrank p 1.9×10-8, 9.7×10-3, and 1.2×10-2). Conclusions: The proposed transformer-based survival prediction model integrates complementary information from diverse input modalities, contributing to improved glioblastoma survival prediction compared to state-of-the-art methods. Consistent performance was observed across institutions supporting model generalizability.
Key facts. Cited by 9 papers in the map (data through 14 Oct 2026). Builds on 15 of its 62 references that are in the map. First posted on arXiv 21 May 2024.
Builds on
15 of 62 references.
References · 15
- 2017Attention Is All You Needcited by 60,361
- 2015Deep Residual Learning for Image Recognitioncited by 52,096
- 2020An Image is Worth 16x16 Words: Transformers for Image Recognition at Scalecited by 30,186
- 2019ViLBERT: Pretraining Task-Agnostic Visiolinguistic Representations for Vision-and-Language Taskscited by 2,222
- 2019Multimodal Transformer for Unaligned Multimodal Language Sequencescited by 645
- 2017Can Spatiotemporal 3D CNNs Retrace the History of 2D CNNs and ImageNet?cited by 551
- 2021The RSNA-ASNR-MICCAI BraTS 2021 Benchmark on Brain Tumor Segmentation and Radiogenomic Classificationcited by 518
- 2021Self-Supervised Pre-Training of Swin Transformers for 3D Medical Image Analysiscited by 422
- 2016DeepSurv: Personalized Treatment Recommender System Using A Cox Proportional Hazards Deep Neural Networkcited by 358
- 2019Continuous and Discrete-Time Survival Prediction with Neural Networkscited by 70
- 2023Advances in Medical Image Analysis with Vision Transformers: A Comprehensive Reviewcited by 62
- 2021The University of California San Francisco Preoperative Diffuse Glioma MRI (UCSF-PDGM) Datasetcited by 43
3 more
- 2022Survival Prediction of Brain Cancer with Incomplete Radiology, Pathology, Genomics, and Demographic Datacited by 25
- 2021Imbalanced Big Data Oversampling: Taxonomy, Algorithms, Software, Guidelines and Future Directionscited by 21
- 2023The Rio Hortega University Hospital Glioblastoma dataset: a comprehensive collection of preoperative, early postoperative and recurrence MRI scans (RHUH-GBM)cited by 11
Built on by
Citing papers per year: 2025: 6; 2026: 3.
9 papers.
- 2025A Self-supervised Multimodal Deep Learning Approach to Differentiate Post-radiotherapy Progression from Pseudoprogression in Glioblastomacited by 4
- 2025Multi-Modal Mamba Modeling for Survival Prediction (M4Survive): Adapting Joint Foundation Model Representationscited by 1
- 2025impuTMAE: Multi-modal Transformer with Masked Pre-training for Missing Modalities Imputation in Cancer Survival Predictioncited by 1
- 2026Rectified flow-based prediction of post-treatment brain MRI from pre-radiotherapy priors for patients with gliomacited by 1
- 2025EAGLE: Efficient Alignment of Generalized Latent Embeddings for Multimodal Survival Prediction with Interpretable Attribution Analysiscited by 0
- 2025The added value for MRI radiomics and deep-learning for glioblastoma prognostication compared to clinical and molecular informationcited by 0
- 2025Multi-Modal Machine Learning Framework for Predicting Early Recurrence of Brain Tumors Using MRI and Clinical Biomarkerscited by 0
- 2026Learning Glioblastoma Tumor Heterogeneity Using Brain Inspired Topological Neural Networkscited by 0
- 2026Trimodal Glioma Representation Alignment via Volumetric Contrastive Learningcited by 0
- 2026Trimodal Glioma Representation Alignment via Volumetric Contrastive Learning12 Jun 2026
- 2026Rectified flow-based prediction of post-treatment brain MRI from pre-radiotherapy priors for patients with glioma9 Mar 2026
- 2026Learning Glioblastoma Tumor Heterogeneity Using Brain Inspired Topological Neural Networks11 Feb 2026
- 2025Multi-Modal Machine Learning Framework for Predicting Early Recurrence of Brain Tumors Using MRI and Clinical Biomarkers1 Sep 2025
- 2025impuTMAE: Multi-modal Transformer with Masked Pre-training for Missing Modalities Imputation in Cancer Survival Prediction8 Aug 2025
- 2025The added value for MRI radiomics and deep-learning for glioblastoma prognostication compared to clinical and molecular information21 Jul 2025
- 2025EAGLE: Efficient Alignment of Generalized Latent Embeddings for Multimodal Survival Prediction with Interpretable Attribution Analysis12 Jun 2025
- 2025Multi-Modal Mamba Modeling for Survival Prediction (M4Survive): Adapting Joint Foundation Model Representations13 Mar 2025
- 2025A Self-supervised Multimodal Deep Learning Approach to Differentiate Post-radiotherapy Progression from Pseudoprogression in Glioblastoma6 Feb 2025